nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB2—bile duct cancer	0.585	0.679	CbGaD
Lapatinib—EGFR—bile duct cancer	0.277	0.321	CbGaD
Lapatinib—ERBB2—gall bladder—bile duct cancer	0.00516	0.155	CbGeAlD
Lapatinib—TAP1—pancreas—bile duct cancer	0.00326	0.0975	CbGeAlD
Lapatinib—PIK3C2B—pancreas—bile duct cancer	0.00306	0.0916	CbGeAlD
Lapatinib—ERBB2—pancreas—bile duct cancer	0.00238	0.0712	CbGeAlD
Lapatinib—Gefitinib—EGFR—bile duct cancer	0.00236	1	CrCbGaD
Lapatinib—PI4KB—pancreas—bile duct cancer	0.00223	0.0667	CbGeAlD
Lapatinib—TAP1—liver—bile duct cancer	0.00207	0.0621	CbGeAlD
Lapatinib—PIK3C2B—liver—bile duct cancer	0.00195	0.0583	CbGeAlD
Lapatinib—TAP1—lymph node—bile duct cancer	0.00159	0.0476	CbGeAlD
Lapatinib—ERBB2—liver—bile duct cancer	0.00151	0.0453	CbGeAlD
Lapatinib—PIK3C2B—lymph node—bile duct cancer	0.00149	0.0447	CbGeAlD
Lapatinib—PI4KB—liver—bile duct cancer	0.00142	0.0424	CbGeAlD
Lapatinib—EGFR—liver—bile duct cancer	0.00128	0.0384	CbGeAlD
Lapatinib—ERBB2—lymph node—bile duct cancer	0.00116	0.0347	CbGeAlD
Lapatinib—PI4KB—lymph node—bile duct cancer	0.00109	0.0325	CbGeAlD
Lapatinib—EGFR—lymph node—bile duct cancer	0.000984	0.0295	CbGeAlD
Lapatinib—CYP3A5—pancreas—bile duct cancer	0.000583	0.0175	CbGeAlD
Lapatinib—CYP2C19—liver—bile duct cancer	0.000471	0.0141	CbGeAlD
Lapatinib—CYP2C8—liver—bile duct cancer	0.000411	0.0123	CbGeAlD
Lapatinib—CYP3A5—liver—bile duct cancer	0.000371	0.0111	CbGeAlD
Lapatinib—ABCB1—pancreas—bile duct cancer	0.00031	0.00928	CbGeAlD
Lapatinib—CYP3A4—liver—bile duct cancer	0.000279	0.00834	CbGeAlD
Lapatinib—ABCB1—liver—bile duct cancer	0.000197	0.0059	CbGeAlD
Lapatinib—ABCB1—lymph node—bile duct cancer	0.000151	0.00453	CbGeAlD
Lapatinib—EGFR—Downstream signaling of activated FGFR—KRAS—bile duct cancer	4.76e-05	0.000465	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—IL6—bile duct cancer	4.75e-05	0.000464	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—NRAS—bile duct cancer	4.73e-05	0.000462	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—FAR2—bile duct cancer	4.73e-05	0.000462	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—NRAS—bile duct cancer	4.71e-05	0.00046	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	4.71e-05	0.00046	CbGpPWpGaD
Lapatinib—EGFR—Disease—IDH1—bile duct cancer	4.7e-05	0.000459	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—KRAS—bile duct cancer	4.68e-05	0.000458	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—IL6—bile duct cancer	4.68e-05	0.000457	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TGFB1—bile duct cancer	4.66e-05	0.000456	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL6—bile duct cancer	4.66e-05	0.000456	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	4.57e-05	0.000446	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—HRAS—bile duct cancer	4.49e-05	0.000439	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—KRAS—bile duct cancer	4.47e-05	0.000437	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—NRAS—bile duct cancer	4.46e-05	0.000436	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP2—bile duct cancer	4.45e-05	0.000435	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	4.45e-05	0.000435	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—KRAS—bile duct cancer	4.45e-05	0.000435	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—bile duct cancer	4.44e-05	0.000434	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—KRAS—bile duct cancer	4.43e-05	0.000433	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—KRAS—bile duct cancer	4.4e-05	0.000431	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HRAS—bile duct cancer	4.39e-05	0.000429	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—NRAS—bile duct cancer	4.38e-05	0.000428	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—bile duct cancer	4.34e-05	0.000424	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—KRAS—bile duct cancer	4.32e-05	0.000422	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB2—bile duct cancer	4.31e-05	0.000421	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	4.31e-05	0.000421	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—IL6—bile duct cancer	4.3e-05	0.00042	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	4.26e-05	0.000417	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—HRAS—bile duct cancer	4.23e-05	0.000413	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.21e-05	0.000411	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—bile duct cancer	4.2e-05	0.000411	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—bile duct cancer	4.18e-05	0.000409	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—KRAS—bile duct cancer	4.14e-05	0.000405	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—KRAS—bile duct cancer	4.14e-05	0.000405	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—KRAS—bile duct cancer	4.14e-05	0.000405	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	4.12e-05	0.000403	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—KRAS—bile duct cancer	4.11e-05	0.000401	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TGFB1—bile duct cancer	4.07e-05	0.000398	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—KRAS—bile duct cancer	4.07e-05	0.000398	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—KRAS—bile duct cancer	4.05e-05	0.000396	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—bile duct cancer	4.04e-05	0.000395	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—HRAS—bile duct cancer	4.04e-05	0.000395	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—bile duct cancer	3.99e-05	0.00039	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—bile duct cancer	3.98e-05	0.000389	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—ERBB2—bile duct cancer	3.9e-05	0.000381	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.9e-05	0.000381	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—NRAS—bile duct cancer	3.87e-05	0.000378	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—bile duct cancer	3.87e-05	0.000378	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—bile duct cancer	3.84e-05	0.000375	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—KRAS—bile duct cancer	3.84e-05	0.000375	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RNF43—bile duct cancer	3.82e-05	0.000374	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NRAS—bile duct cancer	3.81e-05	0.000373	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MET—bile duct cancer	3.81e-05	0.000372	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—bile duct cancer	3.81e-05	0.000372	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—bile duct cancer	3.8e-05	0.000371	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	3.78e-05	0.00037	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—bile duct cancer	3.78e-05	0.00037	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—KRAS—bile duct cancer	3.77e-05	0.000369	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—bile duct cancer	3.76e-05	0.000368	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—bile duct cancer	3.74e-05	0.000366	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NRAS—bile duct cancer	3.72e-05	0.000363	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—bile duct cancer	3.69e-05	0.000361	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	3.67e-05	0.000359	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—NRAS—bile duct cancer	3.66e-05	0.000358	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS2—bile duct cancer	3.64e-05	0.000356	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—bile duct cancer	3.64e-05	0.000355	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—bile duct cancer	3.62e-05	0.000354	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFBR2—bile duct cancer	3.62e-05	0.000353	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—bile duct cancer	3.6e-05	0.000352	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—bile duct cancer	3.58e-05	0.00035	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS2—bile duct cancer	3.58e-05	0.00035	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFBR2—bile duct cancer	3.56e-05	0.000348	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	3.55e-05	0.000347	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—bile duct cancer	3.53e-05	0.000345	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—bile duct cancer	3.52e-05	0.000344	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—bile duct cancer	3.52e-05	0.000344	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—bile duct cancer	3.52e-05	0.000344	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—bile duct cancer	3.49e-05	0.000341	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GNAS—bile duct cancer	3.49e-05	0.000341	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—bile duct cancer	3.47e-05	0.000339	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.47e-05	0.000339	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—bile duct cancer	3.46e-05	0.000338	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—bile duct cancer	3.44e-05	0.000337	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GNAS—bile duct cancer	3.44e-05	0.000336	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SMAD4—bile duct cancer	3.42e-05	0.000334	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—bile duct cancer	3.39e-05	0.000331	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—bile duct cancer	3.37e-05	0.00033	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—bile duct cancer	3.37e-05	0.00033	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—bile duct cancer	3.37e-05	0.00033	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SMAD4—bile duct cancer	3.37e-05	0.000329	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—bile duct cancer	3.35e-05	0.000327	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—bile duct cancer	3.34e-05	0.000327	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—bile duct cancer	3.33e-05	0.000326	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KRAS—bile duct cancer	3.33e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—bile duct cancer	3.33e-05	0.000325	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—bile duct cancer	3.31e-05	0.000324	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—bile duct cancer	3.3e-05	0.000322	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KRAS—bile duct cancer	3.28e-05	0.000321	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NRAS—bile duct cancer	3.28e-05	0.000321	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—bile duct cancer	3.26e-05	0.000319	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—bile duct cancer	3.21e-05	0.000313	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KRAS—bile duct cancer	3.2e-05	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP2—bile duct cancer	3.18e-05	0.000311	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KRAS—bile duct cancer	3.15e-05	0.000308	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	3.12e-05	0.000305	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—bile duct cancer	3.07e-05	0.0003	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—IDH2—bile duct cancer	3.06e-05	0.000299	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	3.01e-05	0.000295	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	3.01e-05	0.000294	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	2.99e-05	0.000292	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—NRAS—bile duct cancer	2.97e-05	0.00029	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	2.94e-05	0.000287	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB2—bile duct cancer	2.92e-05	0.000285	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FAR2—bile duct cancer	2.91e-05	0.000285	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	2.89e-05	0.000282	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GNAS—bile duct cancer	2.85e-05	0.000279	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—bile duct cancer	2.83e-05	0.000277	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KRAS—bile duct cancer	2.82e-05	0.000276	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	2.8e-05	0.000273	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—bile duct cancer	2.79e-05	0.000273	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ERBB2—bile duct cancer	2.78e-05	0.000272	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—bile duct cancer	2.72e-05	0.000266	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—bile duct cancer	2.71e-05	0.000265	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB2—bile duct cancer	2.69e-05	0.000263	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—bile duct cancer	2.68e-05	0.000262	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—bile duct cancer	2.67e-05	0.000261	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—bile duct cancer	2.67e-05	0.000261	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—IDH2—bile duct cancer	2.65e-05	0.000259	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—bile duct cancer	2.63e-05	0.000257	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—IDH1—bile duct cancer	2.63e-05	0.000257	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—KRAS—bile duct cancer	2.55e-05	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFBR2—bile duct cancer	2.5e-05	0.000244	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HGF—bile duct cancer	2.48e-05	0.000243	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB2—bile duct cancer	2.46e-05	0.00024	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—bile duct cancer	2.4e-05	0.000235	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—bile duct cancer	2.39e-05	0.000233	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—IDH2—bile duct cancer	2.37e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Disease—SMAD4—bile duct cancer	2.36e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB2—bile duct cancer	2.36e-05	0.000231	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—IDH2—bile duct cancer	2.31e-05	0.000226	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—bile duct cancer	2.3e-05	0.000224	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—IDH1—bile duct cancer	2.28e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NRAS—bile duct cancer	2.25e-05	0.00022	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NRAS—bile duct cancer	2.22e-05	0.000217	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	2.17e-05	0.000212	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—bile duct cancer	2.17e-05	0.000212	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.12e-05	0.000208	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NRAS—bile duct cancer	2.12e-05	0.000207	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.08e-05	0.000204	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NRAS—bile duct cancer	2.08e-05	0.000203	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—bile duct cancer	2.08e-05	0.000203	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—bile duct cancer	2.05e-05	0.000201	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NRAS—bile duct cancer	2.05e-05	0.0002	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—IDH1—bile duct cancer	2.03e-05	0.000199	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—bile duct cancer	2.02e-05	0.000198	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—IDH1—bile duct cancer	1.99e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—bile duct cancer	1.97e-05	0.000192	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	1.97e-05	0.000192	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KRAS—bile duct cancer	1.94e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—bile duct cancer	1.93e-05	0.000189	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KRAS—bile duct cancer	1.91e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—bile duct cancer	1.9e-05	0.000186	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—bile duct cancer	1.9e-05	0.000185	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB2—bile duct cancer	1.89e-05	0.000184	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NRAS—bile duct cancer	1.87e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—bile duct cancer	1.87e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—KRAS—bile duct cancer	1.82e-05	0.000178	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NRAS—bile duct cancer	1.8e-05	0.000176	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KRAS—bile duct cancer	1.79e-05	0.000175	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—bile duct cancer	1.76e-05	0.000172	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—bile duct cancer	1.76e-05	0.000172	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	1.75e-05	0.000171	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFBR2—bile duct cancer	1.75e-05	0.000171	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC5A5—bile duct cancer	1.74e-05	0.00017	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNAS—bile duct cancer	1.69e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMAD4—bile duct cancer	1.65e-05	0.000162	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—bile duct cancer	1.65e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—bile duct cancer	1.64e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—bile duct cancer	1.62e-05	0.000159	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—bile duct cancer	1.62e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—bile duct cancer	1.61e-05	0.000157	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—bile duct cancer	1.58e-05	0.000154	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—bile duct cancer	1.55e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—bile duct cancer	1.55e-05	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—bile duct cancer	1.55e-05	0.000151	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—bile duct cancer	1.52e-05	0.000149	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC5A5—bile duct cancer	1.5e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—bile duct cancer	1.5e-05	0.000147	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—bile duct cancer	1.48e-05	0.000145	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NRAS—bile duct cancer	1.46e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—bile duct cancer	1.46e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NRAS—bile duct cancer	1.44e-05	0.00014	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—bile duct cancer	1.44e-05	0.00014	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB2—bile duct cancer	1.43e-05	0.00014	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—IDH2—bile duct cancer	1.42e-05	0.000139	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.41e-05	0.000138	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—bile duct cancer	1.37e-05	0.000134	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—bile duct cancer	1.35e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GNAS—bile duct cancer	1.35e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC5A5—bile duct cancer	1.34e-05	0.000131	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—bile duct cancer	1.33e-05	0.00013	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—bile duct cancer	1.33e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB2—bile duct cancer	1.32e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—bile duct cancer	1.31e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—bile duct cancer	1.31e-05	0.000128	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC5A5—bile duct cancer	1.31e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—bile duct cancer	1.31e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—bile duct cancer	1.29e-05	0.000126	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.26e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—bile duct cancer	1.25e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—bile duct cancer	1.24e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—IDH1—bile duct cancer	1.22e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—NRAS—bile duct cancer	1.19e-05	0.000117	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GNAS—bile duct cancer	1.17e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—bile duct cancer	1.11e-05	0.000109	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—bile duct cancer	1.1e-05	0.000107	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NRAS—bile duct cancer	1.09e-05	0.000107	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—bile duct cancer	1.07e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—bile duct cancer	1.05e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GNAS—bile duct cancer	1.04e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—bile duct cancer	1.03e-05	0.0001	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—bile duct cancer	1.02e-05	9.97e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GNAS—bile duct cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NRAS—bile duct cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—bile duct cancer	1.01e-05	9.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—bile duct cancer	9.38e-06	9.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—bile duct cancer	9.35e-06	9.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB2—bile duct cancer	9.26e-06	9.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—bile duct cancer	8.72e-06	8.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—bile duct cancer	8.66e-06	8.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—bile duct cancer	8.35e-06	8.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC5A5—bile duct cancer	8.07e-06	7.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—bile duct cancer	7.97e-06	7.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—bile duct cancer	7.94e-06	7.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—bile duct cancer	7.63e-06	7.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—bile duct cancer	7.36e-06	7.19e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—bile duct cancer	7.24e-06	7.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NRAS—bile duct cancer	7.04e-06	6.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—bile duct cancer	7.04e-06	6.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—bile duct cancer	6.55e-06	6.4e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—bile duct cancer	6.27e-06	6.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GNAS—bile duct cancer	6.27e-06	6.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—bile duct cancer	6.06e-06	5.93e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—bile duct cancer	5.6e-06	5.47e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—bile duct cancer	5.47e-06	5.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—bile duct cancer	5.39e-06	5.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—bile duct cancer	5.15e-06	5.04e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—bile duct cancer	4.93e-06	4.82e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—bile duct cancer	3.37e-06	3.29e-05	CbGpPWpGaD
